#USA #New York #Class Action #Securities Fraud #Iovance

Levi & Korsinsky Reminds Iovance Investors

Levi & Korsinsky, LLP, a renowned firm specializing in securities fraud litigation, has notified investors in Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) about an important update concerning a class action lawsuit filed against the company. The class action is poised to impact several shareholders who experienced financial losses attributable to the alleged misrepresentation of facts by Iovance from May 9, 2024, to May 8, 2025.

Background of the Lawsuit

The class action seeks to address grievances from investors who believe that they were misled by false statements made by the company regarding its growth potential. According to the complaint, during the specified class period, Iovance's executives provided overly optimistic outlooks while simultaneously withholding crucial adverse developments that could significantly affect the firm's performance and investor sentiments. This is particularly critical following a disappointing financial report released by Iovance on July 25, 2024.

The report indicated that Iovance's revenue guidance for fiscal year 2024 was significantly lowered, resulting in a dramatic drop in stock prices. Specifically, the company's stock plummeted from $3.17 to $1.75 in a single day, representing a staggering decline of nearly 45%. This sharp fall raised red flags, prompting shareholders to question the accuracy of the company's earlier positive statements.

Details of Class Action Claims

Investors who saw their investment values decrease due to the alleged securities fraud may qualify as class members in this lawsuit. Levi & Korsinsky is inviting affected investors to step forward and possibly take on the role of lead plaintiff by the critical deadline of July 14, 2025. This opportunity allows investors to advocate for collective compensation without incurring out-of-pocket costs or legal expenses.

Next Steps for Affected Shareholders

Shareholders who suffered loss during the class period are encouraged to contact Levi & Korsinsky to discuss their eligibility for participating in the lawsuit. Interested investors can reach out via the firm's website or directly contact attorneys Joseph E. Levi or Ed Korsinsky for more specific inquiries. The firm prides itself on its successful track record of gaining substantial settlements for hundreds of millions of dollars over the past two decades, catering to shareholders seeking justice in the securities arena.

Why Choose Levi & Korsinsky?

Levi & Korsinsky has built a robust reputation as one of the leading securities litigation firms in the United States. With a dedicated team of more than 70 professionals, the firm has been recognized repeatedly in ISS Securities Class Action Services' Top 50 Report. Their commitment to fighting for shareholder rights has established them as trusted advocates for those impacted by securities violations.

Conclusion

The deadline of July 14, 2025, is looming for investors affected by the Iovance class action lawsuit. This case underscores the importance of corporate responsibility and the need for truthful communication from public companies. Victims of securities fraud are urged to consider their options by reaching out to certified law professionals skilled in handling class action lawsuits. As events unfold, stakeholders remain optimistic that justice will prevail for investors who have endured financial challenges due to potentially misleading information from the company.